Live Investor briefing

Live Investor briefing

Live Investor briefing

Prescient Therapeutics (ASX: PTX)

Friday, 10th February 12pm (AEDT)

Please join Prescient CEO and managing director Steven Yatomi-Clarke for an investor briefing. In this session, Steven will discuss

How PTX is taking the cancer treatment conversation from ‘fight’ to ‘cure’

How the company can potentially make any CAR-T developer’s therapies more effective, cheaper and safer

How its modular platform allows PTX to partner with any CAR-T developer giving them a ‘shovels to the gold rush’ position

It will be a fascinating look into why Prescient’s highly scalable business model gives them multiple shots on goal in oncology.

This is a live and interactive online session, and participants are encouraged to ask questions. Spots are limited, so secure yours today.

Can’t make this time, register to receive the replay.

https://prescienttherapeutics.investorportal.com.au/